ID

38222

Beschreibung

A Phase II Trial Testing Oral Administration of Lucitanib in Patients With Fibroblast Growth Factor Receptor (FGFR)1-amplified or Non-amplified Estrogen Receptor Positive Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02053636

Link

https://clinicaltrials.gov/show/NCT02053636

Stichworte

Versionen (1)
  1. 29.09.19 29.09.19 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

29. September 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Breast Cancer NCT02053636

Englisch

Eligibility Breast Cancer NCT02053636

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed breast adenocarcinoma.
Beschreibung

Breast adenocarcinoma

Datentyp

boolean

Alias
UMLS CUI [1]
C0858252
presence of an accessible metastatic lesion for biopsy or at least one archived metastatic tumour sample.
Beschreibung

Metastatic Lesion Amenable Biopsy | Tumor tissue sample metastatic Quantity

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1513183
UMLS CUI [1,2]
C3900053
UMLS CUI [1,3]
C0005558
UMLS CUI [2,1]
C0475358
UMLS CUI [2,2]
C1522484
UMLS CUI [2,3]
C1265611
prior first-line hormonal therapy in the metastatic setting.
Beschreibung

First line Hormone Therapy Neoplasm Metastasis

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1708063
UMLS CUI [1,2]
C0279025
UMLS CUI [1,3]
C0027627
demonstrated progression of disease by radiological or clinical assessment.
Beschreibung

Disease Progression

Datentyp

boolean

Alias
UMLS CUI [1]
C0242656
female patient, aged ≥18 years old.
Beschreibung

Gender | Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
estimated life expectancy >3 months.
Beschreibung

Life Expectancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0023671
normal left ventricular function
Beschreibung

Left Ventricular Function

Datentyp

boolean

Alias
UMLS CUI [1]
C0080310
adequate haematological, hepatic and renal functions.
Beschreibung

Hematologic function | Liver function | Renal function

Datentyp

boolean

Alias
UMLS CUI [1]
C0221130
UMLS CUI [2]
C0232741
UMLS CUI [3]
C0232804
for women with childbearing potential, a negative pregnancy test prior to initiation of the study drug and willingness to use an effective contraception.
Beschreibung

Childbearing Potential Pregnancy test negative | Childbearing Potential Contraceptive methods

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0427780
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0700589
ability to swallow oral capsules.
Beschreibung

Able to swallow Capsules

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2712086
UMLS CUI [1,2]
C0006935
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
more than two lines of chemotherapy and two lines of hormonal therapy with or without targeted therapy in the metastatic setting.
Beschreibung

Chemotherapy Quantity Neoplasm Metastasis | Hormone Therapy Quantity Neoplasm Metastasis | Targeted Therapy Neoplasm Metastasis | Targeted Therapy Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0027627
UMLS CUI [2,1]
C0279025
UMLS CUI [2,2]
C1265611
UMLS CUI [2,3]
C0027627
UMLS CUI [3,1]
C2985566
UMLS CUI [3,2]
C0027627
UMLS CUI [4,1]
C2985566
UMLS CUI [4,2]
C0332197
previous treatment with bevacizumab within 3 months of first dose of investigational medicinal product.
Beschreibung

bevacizumab

Datentyp

boolean

Alias
UMLS CUI [1]
C0796392
active central nervous system metastases, cerebral oedema, and/or progressive growth.
Beschreibung

CNS metastases | Cerebral Edema | Growth Progressive

Datentyp

boolean

Alias
UMLS CUI [1]
C0686377
UMLS CUI [2]
C0006114
UMLS CUI [3,1]
C0018270
UMLS CUI [3,2]
C0205329
patients with impaired cardiac function.
Beschreibung

Decreased cardiac function

Datentyp

boolean

Alias
UMLS CUI [1]
C0232166
uncontrolled arterial hypertension
Beschreibung

Uncontrolled hypertension

Datentyp

boolean

Alias
UMLS CUI [1]
C1868885
patients with history of thrombotic disorders or hereditary risk factors of thromboembolic events
Beschreibung

Thrombosis | Risk factors Hereditary Thromboembolic event

Datentyp

boolean

Alias
UMLS CUI [1]
C0040053
UMLS CUI [2,1]
C0035648
UMLS CUI [2,2]
C0439660
UMLS CUI [2,3]
C0040038
serum potassium level below lower limit of normal
Beschreibung

Serum potassium decreased

Datentyp

boolean

Alias
UMLS CUI [1]
C0595885
uncontrolled hypothyroidism.
Beschreibung

Hypothyroidism Uncontrolled

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020676
UMLS CUI [1,2]
C0205318
pregnant or breastfeeding women.
Beschreibung

Pregnancy | Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Breast Cancer NCT02053636

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Breast adenocarcinoma
Item
histologically confirmed breast adenocarcinoma.
boolean
C0858252 (UMLS CUI [1])
Metastatic Lesion Amenable Biopsy | Tumor tissue sample metastatic Quantity
Item
presence of an accessible metastatic lesion for biopsy or at least one archived metastatic tumour sample.
boolean
C1513183 (UMLS CUI [1,1])
C3900053 (UMLS CUI [1,2])
C0005558 (UMLS CUI [1,3])
C0475358 (UMLS CUI [2,1])
C1522484 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
First line Hormone Therapy Neoplasm Metastasis
Item
prior first-line hormonal therapy in the metastatic setting.
boolean
C1708063 (UMLS CUI [1,1])
C0279025 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])
Disease Progression
Item
demonstrated progression of disease by radiological or clinical assessment.
boolean
C0242656 (UMLS CUI [1])
Gender | Age
Item
female patient, aged ≥18 years old.
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Life Expectancy
Item
estimated life expectancy >3 months.
boolean
C0023671 (UMLS CUI [1])
Left Ventricular Function
Item
normal left ventricular function
boolean
C0080310 (UMLS CUI [1])
Hematologic function | Liver function | Renal function
Item
adequate haematological, hepatic and renal functions.
boolean
C0221130 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
Childbearing Potential Pregnancy test negative | Childbearing Potential Contraceptive methods
Item
for women with childbearing potential, a negative pregnancy test prior to initiation of the study drug and willingness to use an effective contraception.
boolean
C3831118 (UMLS CUI [1,1])
C0427780 (UMLS CUI [1,2])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
Able to swallow Capsules
Item
ability to swallow oral capsules.
boolean
C2712086 (UMLS CUI [1,1])
C0006935 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Chemotherapy Quantity Neoplasm Metastasis | Hormone Therapy Quantity Neoplasm Metastasis | Targeted Therapy Neoplasm Metastasis | Targeted Therapy Absent
Item
more than two lines of chemotherapy and two lines of hormonal therapy with or without targeted therapy in the metastatic setting.
boolean
C0392920 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])
C0279025 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0027627 (UMLS CUI [2,3])
C2985566 (UMLS CUI [3,1])
C0027627 (UMLS CUI [3,2])
C2985566 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
bevacizumab
Item
previous treatment with bevacizumab within 3 months of first dose of investigational medicinal product.
boolean
C0796392 (UMLS CUI [1])
CNS metastases | Cerebral Edema | Growth Progressive
Item
active central nervous system metastases, cerebral oedema, and/or progressive growth.
boolean
C0686377 (UMLS CUI [1])
C0006114 (UMLS CUI [2])
C0018270 (UMLS CUI [3,1])
C0205329 (UMLS CUI [3,2])
Decreased cardiac function
Item
patients with impaired cardiac function.
boolean
C0232166 (UMLS CUI [1])
Uncontrolled hypertension
Item
uncontrolled arterial hypertension
boolean
C1868885 (UMLS CUI [1])
Thrombosis | Risk factors Hereditary Thromboembolic event
Item
patients with history of thrombotic disorders or hereditary risk factors of thromboembolic events
boolean
C0040053 (UMLS CUI [1])
C0035648 (UMLS CUI [2,1])
C0439660 (UMLS CUI [2,2])
C0040038 (UMLS CUI [2,3])
Serum potassium decreased
Item
serum potassium level below lower limit of normal
boolean
C0595885 (UMLS CUI [1])
Hypothyroidism Uncontrolled
Item
uncontrolled hypothyroidism.
boolean
C0020676 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
pregnant or breastfeeding women.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video